Empa-Kidney

What is the prevalence of diabetes in Pakistani adults?

• 25%

• 15%

• 35%

• 5%

Which of the following is not an SGLT2 inhinbitor?

• Gluroflozin

• Empagliflozin

• Ertugliflozin

• Canagliflozin

SGLT2 stands for?

• Sodium glucose Transporter 2

• Sodium Glucose Lactose Tolerance 2

• Sugar Glucose Transporter 2

• Sodium Glucose Type 2

Empa - Kidney was a

• Randomised controlled trial

• Case study

• Observational study

• Open-label study

In light of Empa kidney trial, giving empagliflozin to a patient with CKD stage 2 would,

• Increase his risk of end stage renal disease

• Increase his risk of a heart attack

• Decrease his risk of stroke

• Increase his risk of developing diabetes